RHJA
Rice Hall James & Associates’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Sell |
160,110
-686
| -0.4% | -$118K | 1.49% | 20 |
|
|
2025
Q1 | $25.1M | Sell |
160,796
-3,092
| -2% | -$482K | 1.47% | 20 |
|
|
2024
Q4 | $22.6M | Buy |
163,888
+3,274
| +2% | +$451K | 1.24% | 22 |
|
|
2024
Q3 | $24M | Buy |
160,614
+8,958
| +6% | +$1.34M | 1.3% | 22 |
|
|
2024
Q2 | $20.7M | Sell |
151,656
-10,756
| -7% | -$1.47M | 1.24% | 19 |
|
|
2024
Q1 | $24.6M | Sell |
162,412
-6,471
| -4% | -$978K | 1.4% | 18 |
|
|
2023
Q4 | $21.3M | Sell |
168,883
-904
| -0.5% | -$114K | 1.23% | 20 |
|
|
2023
Q3 | $15.9M | Sell |
169,787
-3,676
| -2% | -$344K | 1.01% | 27 |
|
|
2023
Q2 | $15.5M | Buy |
173,463
+18,535
| +12% | +$1.65M | 0.88% | 34 |
|
|
2023
Q1 | $16.6M | Buy |
154,928
+9,189
| +6% | +$985K | 0.94% | 29 |
|
|
2022
Q4 | $17.8M | Buy |
145,739
+9,294
| +7% | +$1.14M | 1.02% | 27 |
|
|
2022
Q3 | $14.1M | Sell |
136,445
-26,543
| -16% | -$2.74M | 0.82% | 37 |
|
|
2022
Q2 | $15.2M | Buy |
162,988
+28,088
| +21% | +$2.61M | 0.73% | 41 |
|
|
2022
Q1 | $15.8M | Buy |
134,900
+35,039
| +35% | +$4.11M | 0.63% | 49 |
|
|
2021
Q4 | $13.4M | Buy |
99,861
+23,095
| +30% | +$3.11M | 0.48% | 52 |
|
|
2021
Q3 | $12.2M | Buy |
76,766
+36,593
| +91% | +$5.83M | 0.45% | 63 |
|
|
2021
Q2 | $5.29M | Hold |
40,173
| – | – | 0.19% | 90 |
|
|
2021
Q1 | $5.18M | Sell |
40,173
-1,810
| -4% | -$233K | 0.17% | 109 |
|
|
2020
Q4 | $7M | Buy |
41,983
+19,696
| +88% | +$3.28M | 0.25% | 78 |
|
|
2020
Q3 | $3.44M | Buy |
+22,287
| New | +$3.44M | 0.14% | 119 |
|